1. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
2. | | Recruiting | A 14-day study of Racivir when used in combination in HIV-Infected Males Condition: HIV Infections |
3. | | Recruiting | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
4. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas Conditions: adult solid tumor; Leukemia; Lymphoma |
5. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma Condition: Cancer |
6. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ... |
7. | | Recruiting | 4-Day-A-Week Treatment Plan for HIV Infected Adolescents Condition: HIV Infections |
8. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection Condition: HIV Infections |
9. | | Recruiting | Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy Conditions: HIV Infections; Peripheral Nervous System Diseases |
10. | | Recruiting | Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients Condition: HIV Infections |
11. | | Recruiting | Acupuncture and Moxa: A RCT for Chronic Diarrhea in HIV Patients Condition: HIV Infections |
12. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |
13. | | Recruiting | Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections |
14. | | Recruiting | Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome Conditions: Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome |
15. | | Recruiting | Alternative Dosing Strategy for Anti-HIV Drugs Condition: HIV Infections |
16. | | Recruiting | Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy Condition: HIV Infection |
17. | | Recruiting | Anidulafungin in Treating Immunocompromised Children With Neutropenia Conditions: Infection; Neutropenia; unspecified childhood solid tumor, protocol specific |
18. | | Recruiting | Anidulafungin versus Fluconazole in the Treatment of Candidemia Conditions: Candida; Candidiasis |
19. | | Recruiting | Anti-CD20 in Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic |
20. | | Recruiting | Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children Condition: HIV Infections |
21. | | Recruiting | Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents Condition: HIV Infections |
22. | | Recruiting | Anti-HIV Drugs During Pregnancy Condition: HIV Infections |
23. | | Not yet recruiting | Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis Conditions: HIV Infections; Tuberculosis |
24. | | Not yet recruiting | Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV Condition: HIV Infections |
25. | | Recruiting | Anti-Tac for Treatment of Leukemia Conditions: HTLV-I Infection; T Cell Leukemia |
26. | | Recruiting | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection |
27. | | Recruiting | Antibiotic Treatment for Patients with Infections of Short Term In-dwelling Vascular Catheters Due to a Specific Bacteria (Gram Positive Bacteria) Conditions: Bacterial Infections; Gram-Positive Bacterial Infections; Bacteremia |
28. | | Recruiting | Antibody Production in Immune Disorders Condition: Immunologic Disease |
29. | | Not yet recruiting | Antihyperlipidemic Effects of Oyster Mushrooms Conditions: HIV Infections; Hyperlipidemia |
30. | | Recruiting | Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma Condition: epidemic Kaposi's sarcoma |
31. | | Recruiting | Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients Conditions: Anemia, Sickle Cell; Pneumonia |
32. | | Recruiting | Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions Condition: Kaposi's Sarcoma |
33. | | Recruiting | Assessment of oral acyclovir in neonates with HSV involving the CNS Condition: Herpes Simplex |
34. | | Recruiting | Assessment of Patients with Multiple Sclerosis (MS) Conditions: Herpesviridae Infection; HTLV-I Infection; Multiple Sclerosis; Tropical Spastic Paraparesis; Vasculitis |
35. | | Recruiting | Assessment of pleconaril for treatment of enteroviral sepsis syndrome in neonates Condition: Sepsis |
36. | | Recruiting | Assessment of valganciclovir in neonates with CMV Condition: Cytomegalovirus Infections |
37. | | Recruiting | Atazanavir Used in Combination with Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents Condition: HIV Infections |
38. | | Recruiting | Atazanavir/Ritonavir Maintenance Therapy Condition: HIV Infections |
39. | | Recruiting | Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Condition: Lupus Erythematosus, Systemic |
40. | | Recruiting | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
41. | | Not yet recruiting | Azithromycin in Combination with Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum Infection in Semi-Immune Adults Condition: Plasmodium falciparum Malaria |
42. | | Recruiting | Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America Condition: Plasmodium falciparum Malaria |
43. | | Recruiting | Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Uganda Condition: Plasmodium falciparum Malaria |
44. | | Recruiting | Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Jakarta, Indonesia Condition: Plasmodium falciparum Malaria |
45. | | Recruiting | Azithromycin/Bicillin for treatment of early syphilis Condition: Syphilis |
46. | | Not yet recruiting | BCX-1777 in Treating Patients With Recurrent or Refractory Advanced T-Cell Leukemia or T-Cell Lymphoma Conditions: acute leukemia; adult T-cell leukemia and lymphoma; childhood lymphoblastic lymphoma; Non-Hodgkin's Lymphoma; Prolymphocytic Leukemia |
47. | | Recruiting | Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent mantle cell lymphoma; anaplastic large cell lymphoma |
48. | | Recruiting | Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients Conditions: Kaposi's Sarcoma; HIV Infections; HIV Seronegativity |
49. | | Recruiting | Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma |
50. | | Recruiting | The Biology of HIV Transmission Condition: HIV Infections |